The selection of biomarkers for early detection involves several criteria. These include specificity, sensitivity, and the ability to indicate early changes before clinical symptoms appear. Biomarkers should be easily accessible in bodily fluids like blood or urine and have a well-understood relationship with specific toxic exposures.
